Caricamento...
Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance
BACKGROUND: Deleterious variants in the tumour suppressor BRCA1 are known to cause hereditary breast and ovarian cancer syndrome (HBOC). Missense variants in BRCA1 pose a challenge in clinical care, as their effect on protein functionality often remains unknown. Many of the pathogenic missense varia...
Salvato in:
| Pubblicato in: | Hum Genomics |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6247502/ https://ncbi.nlm.nih.gov/pubmed/30458859 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40246-018-0183-1 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|